NOVOS
Founded 2018 · 34 employees on LinkedIn · 8 known investors
Find your way into NOVOS
Sign up to see every warm intro you have to NOVOS
- Paths you didn't know you had: your email and LinkedIn already hold routes to the NOVOS team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
NOVOS is a longevity biotechnology company that develops science-validated supplement formulations and aging assessment tools designed to target the biological mechanisms of aging rather than disease symptoms. The company serves consumers seeking to extend healthspan through evidence-based products backed by clinical trials and mechanistic research.
Founders & leadership
NOVOS was founded in 2018 by Chris Mirabile.

Investors · 8
How we know: Fab Co-Creation Studio Ventures's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Resolute Ventures's portfolio page · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: UNCOMMON DENOMINATOR's portfolio page · funding news · Not right? Tell us
How we know: calcalistech.com · Not right? Tell us
How we know: funding news · calcalistech.com · Not right? Tell us
Also in the syndicate · 1
Funding
SEC filings, press & company announcements- Undisclosed amountSeed roundApr 2022
MizMaa Ventures (lead), Gal Ventures, Kaedan Capital, Remagine ventures
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does NOVOS do?
- NOVOS is a longevity biotechnology company that develops science-validated supplement formulations and aging assessment tools designed to target the biological mechanisms of aging rather than disease symptoms. The company serves consumers seeking to extend healthspan through evidence-based products backed by clinical trials and mechanistic research.
- Who founded NOVOS?
- NOVOS was founded by Chris Mirabile in 2018.
- Who are NOVOS's investors?
- NOVOS's investors include Cornucopian Capital Management, Fab Co-Creation Studio Ventures, Resolute Ventures, UNCOMMON DENOMINATOR, Kaedan Capital, MizMaa Ventures, Remagine Ventures.



.png)
